Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41585-024-00899-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rediscovering citrate as a biomarker for prostate cancer.
Nat Rev Urol
October 2024
Endocrinology-Nephrology Research Axis, Centre de recherche du CHU de Québec, Université Laval, Québec City, Québec, Canada.
The Dead Sea needs salt water… massively bleeding patients need whole blood: The evolution of blood product resuscitation.
Transfus Clin Biol
September 2019
Vitalant, 3636 Boulevard of the Allies, Pittsburgh, PA 15213, USA; Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15269, USA. Electronic address:
Whole blood, that is blood that is not manufactured into its component red blood cells (RBC) plasma, and platelets (PLT) units, was the mainstay of transfusion for many years until it was discovered that the component parts of a blood donation could be stored under different conditions thereby optimizing the storage length of each product. The use of low anti-A and -B titer group O whole blood (LTOWB) has recently been rediscovered for use in massively bleeding trauma patients. Whole blood has several advantages over conventional component therapy for these patients, including simplifying the logistics of the resuscitation, being more concentrated than whole blood that is reconstituted from conventional components, and providing cold-stored PLTs, amongst other benefits.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!